What is the recommended dose of intravenous (IV) iron sucrose for a 13-year-old patient weighing 56 kg with iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Iron Sucrose Dosing for a 56 kg Teenager

For a 56 kg teenager with iron deficiency anemia, administer iron sucrose 200 mg IV per dose, given 2-3 times weekly (on alternate days), with a total cumulative dose of 600-1200 mg depending on severity of anemia and calculated iron deficit. 1, 2

Specific Dosing Protocol

Single Dose Administration

  • Maximum single dose: 200 mg 1, 3
  • Administer as slow IV push over 2-5 minutes OR diluted in 100 mL of 0.9% normal saline infused over 10-30 minutes 3
  • Maximum weekly dose: 500 mg 3

Frequency and Total Dose

  • Give infusions on alternate days, up to 3 times per week 2
  • Typical number of infusions: 2-6 doses (median 3 doses) 2
  • Total cumulative dose range: 400-1200 mg based on severity 2
  • For this 56 kg patient, a reasonable starting total is 600-800 mg (3-4 doses of 200 mg each) 2

Pediatric Safety Evidence

Iron sucrose is well-established as the safest IV iron preparation in children, despite lack of formal European approval for pediatric use 1:

  • In 232 children receiving 1,624 total doses, very few serious adverse reactions occurred 1
  • A randomized study of 145 children/adolescents using doses of 0.5-2 mg/kg showed no anaphylactic reactions 1
  • Iron sucrose is FDA-approved in the USA for children ≥2 years of age 1
  • Real-world pediatric data shows hemoglobin rising from 7.6±2.38 g/dL to 12.4±0.64 g/dL within 31-42 days 2

Administration Safety Protocol

Pre-Administration Requirements

  • No test dose required for iron sucrose (unlike iron dextran) 3
  • However, consider 25 mg test dose over 5 minutes if history of IV iron sensitivities or multiple drug allergies 3
  • Ensure resuscitation equipment, IV epinephrine, diphenhydramine, and trained personnel immediately available 3

Monitoring During Infusion

  • Start infusion slowly for first 5 minutes to assess for reactions 3
  • Monitor vital signs during and after infusion 3
  • Observe patient for 15-60 minutes post-administration 3

Absolute Contraindications

  • Active bacteremia - withhold therapy 3
  • Chronic infection alone is NOT an absolute contraindication if risk/benefit favors treatment 1, 3

Expected Adverse Effects

Common (Generally Mild)

  • Hypotension, nausea, vomiting, diarrhea 3
  • Injection site reactions 2
  • Transient taste perversion 2
  • Overall hypersensitivity reaction rate: approximately 0.5% 1, 3

Serious (Rare)

  • Anaphylaxis may occur but is rare 1
  • Systemic iron toxicity with hepatocellular damage reported when doses exceed 300 mg maximum single dose 1
  • Hypophosphatemia occurs in only 1% of iron sucrose patients (compared to 58% with ferric carboxymaltose) 1, 3

Critical Pitfalls to Avoid

  • Never exceed 200 mg single dose to minimize dose-related anaphylactoid reactions 1, 3
  • Do not administer during active infection, particularly bacteremia 3
  • One pediatric case of systemic iron toxicity occurred with 16 mg/kg dose (approximately 900 mg for a 56 kg patient given as single dose) - this reinforces the 200 mg maximum single dose rule 1
  • The only significant reaction in one pediatric series occurred when dose exceeded the recommended 300 mg maximum 1

Follow-Up Monitoring

  • Recheck hemoglobin and iron studies (ferritin, transferrin saturation) at 4-6 weeks 1
  • Target ferritin >100 ng/mL and transferrin saturation >20% 1
  • Continue monitoring regularly in patients requiring long-term therapy to prevent both deficiency and overload 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Sucrose Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended dosing regimen for intravenous (IV) iron, specifically iron sucrose or ferric gluconate, for a patient with iron deficiency anemia?
What is the duration of intravenous iron infusions for an 86-year-old frail man?
How many 200 mg iron sucrose doses are needed to increase Hb from 6 g/dL to 12 g/dL in a patient with menorrhagia?
What is the recommended dosage for intravenous (IV) iron infusion?
What is the recommended dose and administration schedule of Monoferric (ferric derisomaltose) for a 34-year-old female patient with severe iron deficiency anemia (Hemoglobin 74 g/L, Mean Corpuscular Volume (MCV) 57 fL, ferritin 2 mcg/L, iron 4 umol/L) who has failed oral iron and vitamin C supplementation?
What is the recommended management for a patient with heterogeneous testicles without focal abnormality and epididymal cysts, with no evidence of torsion?
What is the proper protocol for utilizing the Conners Self-Assessment Rating Scale (Conners SRS) to screen for Attention Deficit Hyperactivity Disorder (ADHD) in patients?
What is the diagnosis for a patient with psychologically driven pain?
What does serum creatinine indicate in a deceased patient?
What is the recommended follow-up and management plan for a patient with an abdominal aortic aneurysm (AAA) who has undergone endovascular aneurysm repair (endograft) and has no evidence of endoleak on ultrasound at 1 year and 1.5 years post-procedure?
What is the differential diagnosis and management plan for a young adult with a history of ankylosing spondylitis (AS) presenting with severe epigastric pain and a soft abdomen, without current medication use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.